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LATEST NEWS
DURHAM, N.H.—With the
end of the pandemic
seemingly nowhere in sight,
scientists are still very
focused on finding new or
alternative drugs to treat and
stop the spread of COVID-19. In a first-of-its-kind study,
researchers at the University of New Hampshire have found that
using an already existing drug compound in a new way, known as
drug repurposing, could be successful in blocking the activity of a
key enzyme of the coronavirus, or SARS-CoV-2, which causes
COVID-19.
“The goal was to slow or prevent the spread of the virus by using
a strategic therapeutic that could possibly disrupt key steps in the
viral life cycle at the molecular level, like the first contact with a
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healthy cell or the first step in replicating within an infected cell,”
said Harish Vashisth, associate professor of chemical
engineering.
In their study, recently published in the journal PROTEINS:
Structure, Function, and Bioinformatics, researchers set out to
target a key enzyme responsible for COVID-19, called the main
protease enzyme Mpro, which has become a primary target of
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intense research and therapeutic development because it is
essential for the virus to replicate. In this case, they explored the
inhibiting properties of a derivative of the potent chemical
compound known as Thiadiazolidinones, or TDZD, which are
already being studied as a potential treatment for neurological
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disorders like Parkinson’s Disease. Researchers used a specific
TDZD compound, known as CCG-50014, to target Mpro which
acts like a molecular scissor by cutting up long chains of
polypeptide proteins of the virus into smaller component proteins.
These smaller segments can fold and mature to form new virus
particles. Using molecular dynamics simulations combined with
laboratory experiments, the researchers determined that TDZD
compound was able to inhibit the Mpro enzyme.
“Coronaviruses, like COVID-19, are a notorious group of
infectious agents that include a large class of viruses with RNA
genomes, similar to the human DNA genome, that depend on
well-organized protein structures crucial for viral growth and
replication,” said Vashisth. “These viruses can develop rapid
defenses at the cellular level by orchestrating these layers, or
folding mechanisms, in viral proteins so the key is to find a way to
shut them down.”
RNA viruses are known for causing seasonal epidemics, like
influenza, and can appear as novel virus strains with high fatality
rates (COVID-19, SARS, Zika and Ebola). Researchers say the
need for an alternative drug development pipeline, instead of the
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intensive process of introducing new drugs to market, is illustrated
by the high infection rate of COVID-19 (compared to previous
coronaviruses) and is important for a long-term effective response
to new and reoccurring outbreaks.
This research was supported by grants from the National
Institutes of Health under award numbers R35GM138217,
P20GM113131, and the National Science Foundation under
award number OIA-1757371. The content is solely the
responsibility of the authors and does not necessarily represent
the official views of the funders.
The University of New Hampshire inspires innovation and
transforms lives in our state, nation and world. More than 16,000
students from all 50 states and 71 countries engage with an
award-winning faculty in top-ranked programs in business,
engineering, law, health and human services, liberal arts and the
sciences across more than 200 programs of study. A Carnegie
Classification R1 institution, UNH partners with NASA, NOAA,
NSF and NIH, and received $260 million in competitive external
funding in FY21 to further explore and define the frontiers of land,
sea and space.
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